Skip to Main Content
Contribute Try STAT+ Today

Hello, everyone, and how are you this morning? Despite some tech challenges today, we are hanging in there, as they say. Our official mascot is undeterred and scurrying about the Pharmalot campus. As for us, we are attempting to go about our usual routine, which includes a cup of stimulation and gazing out the window at delightfully sunny skies. Now, though, the time has come to get cracking. So here are a few items of interest to help you along. Hope your day goes well and you have no trouble making your own connections. …

The White House stunned health care experts last month when it declared it was abandoning its efforts to reform drug pricing in the major domestic spending package moving through Congress, but unlike earlier in the talks, moderate Democrats weren’t the holdouts. This time, it was Speaker Nancy Pelosi who dealt the blow, STAT tells us. It was her behind-the-scenes opposition, which has not been previously reported, that prompted the White House to declare the issue dead — a surprising role for Pelosi, given her decades of long support for sweeping efforts to lower drug prices. The multiple near-collapses and resurrections of the recent negotiations over drug-pricing reform underscore how momentous it was, for Democrats, when they finally did announce a drug pricing deal last week.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Create a display name to comment

This name will appear with your comment